First Trust Advisors’s Puma Biotechnology PBYI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.71M Buy
172,627
+42,421
+33% +$373K ﹤0.01% 2087
2026
Q2
$1.06M Buy
130,206
+6,693
+5% +$49K ﹤0.01% 2210
2026
Q1
$789K Buy
123,513
+713
+0.6% +$4.6K ﹤0.01% 2236
2025
Q4
$731K Buy
122,800
+3,021
+3% +$16K ﹤0.01% 2251
2025
Q3
$636K Buy
+119,779
New +$508K ﹤0.01% 2255
2019
Q3
– Sell
-50,987
Closed -$648K – 2456
2019
Q2
$648K Buy
+50,987
New +$1.17M ﹤0.01% 2022
2017
Q4
– Sell
-4,586
Closed -$549K – 2446
2017
Q3
$549K Buy
+4,586
New +$427K ﹤0.01% 2053

Other funds holding PBYI

First Trust Advisors's PBYI Position: Q3 2026 in Review

First Trust Advisors increased its Puma Biotechnology (PBYI) stake by 33% in Q3 2026, buying an estimated $373K and bringing the position to 172,627 shares worth $1.71M. The position accounts for ﹤0.01% of the portfolio, ranked #2087.

First Trust Advisors first reported a position in PBYI in Q3 2017 and has held it in 7 quarters since. 156 funds tracked by Wall St. Rank hold PBYI as of Q3 2026.

  • First Trust Advisors held 172,627 shares of Puma Biotechnology worth $1.71M as of Q3 2026.
  • First Trust Advisors bought 42,421 Puma Biotechnology shares in Q3 2026, an estimated $373K.
  • Puma Biotechnology made up ﹤0.01% of First Trust Advisors's portfolio in Q3 2026, its #2087 holding.
  • First Trust Advisors first reported a position in Puma Biotechnology in Q3 2017 and has held it in 7 quarters since.
  • 156 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2026.

Based on First Trust Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.